Journal article
Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
- Abstract:
- An open-label, randomized controlled trial was carried out in 2011-2012 in the Democratic Republic of the Congo to test the efficacy, safety, and tolerability of the artemisinin-based combination treatments dihydroartemisinin-piperaquine, amodiaquine-artesunate, and artemether-lumefantrine. Six hundred eighty-four children aged 3 to 59 months with uncomplicated Plasmodium falciparum malaria were randomly allocated to each study arm. Children were hospitalized for 3 days, given supervised treatment, and followed up weekly for 42 days. All regimens were well tolerated and rapidly effective. The median parasitemia clearance half-life was 2.2 h, and half-lives were similar between arms (P=0.19). The PCR-uncorrected cure rates by day 42 were 73.0% for amodiaquine-artesunate, 70.2% for artemether-lumefantrine, and 86.3% for dihydroartemisinin-piperaquine (P=0.001). Early treatment failure occurred in three patients (0.5%), one in each arm. The PCR-corrected cure rates were 93.4% for amodiaquine-artesunate, 92.7% for artemether-lumefantrine, and 94.3% for dihydroartemisinin-piperaquine (P=0.78). The last provided a longer posttreatment prophylactic effect than did the other two treatments. The day 7 plasma concentration of piperaquine was below 30 ng/ml in 47% of the children treated with dihydroartemisinin-piperaquine, and the day 7 lumefantrine concentration was below 280 ng/ml in 37.0% of children who received artemether-lumefantrine. Thus, although cure rates were all satisfactory, they could be improved by increasing the dose. (This study has been registered with the International Standard Randomized Controlled Trial Number Register [www.isrctn.org] under registration no. ISRCTN20984426.).
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 628.2KB, Terms of use)
-
- Publisher copy:
- 10.1128/aac.02682-14
Authors
- Publisher:
- American Society for Microbiology
- Journal:
- Antimicrobial agents and chemotherapy More from this journal
- Volume:
- 58
- Issue:
- 9
- Pages:
- 5528-5536
- Publication date:
- 2014-09-01
- DOI:
- EISSN:
-
1098-6596
- ISSN:
-
0066-4804
- Language:
-
English
- UUID:
-
uuid:785224d6-872b-450f-81bd-dedd1271c743
- Local pid:
-
pubs:475820
- Source identifiers:
-
475820
- Deposit date:
-
2014-07-21
Terms of use
- Copyright holder:
- Onyamboko et al
- Copyright date:
- 2014
- Notes:
-
Copyright © 2014 Onyamboko et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record